INmune Bio (INMB) Ownership - Who owns INmune Bio?

Industry: @Biotechnology
19 days until earnings call

Profile

Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 858 964-3720
Employees
17
Web
https://www.inmunebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
179.62M
P/E Ratio
N/A
Total Cash
26M
Projected Growth
N/A
Total Debt
7.94M
Revenue
131K
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash/Share
1.31
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

INMB
Capitalization
180M
P/E Ratio
N/A
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash
26M
Total Cash/Share
1.31
Total Debt
7.94M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
131K
ROE
N/A
Book Value
29M
P/B Ratio
6.19
Cash Flow
N/A
Earnings
-1.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
817K
Current Ratio
1.71
Current Revenue Per Employee
823.53
Dividends Per Share - Security
N/A
EBITDA
-34.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-57.11
Shares Held By Institutions
44.7M
Shares Outstanding - Current
19.8M
Total Liabilities
17.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-12.433
View a ticker or compare two or three
INMB
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 858 964-3720
Employees
17
Web
https://www.inmunebio.com